跳至主要内容
临床试验/ACTRN12622001326785
ACTRN12622001326785尚未招募未知

Clinical validation of circulating cell free DNA [ccfDNA] as a biomarker of metabolic health

Commonwealth Scientific and Industrial Research Organisation0 个研究点目标入组 100 人开始时间: 2022年10月12日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 55 Years(—)
性别
All

入选标准

  • 1.Willing to provide written Informed Consent
  • 2.Aged from >=18 to <56 years of age at clinic visit
  • 3.BMI >=30 and <=35 kg/m2 confirmed at visit
  • 4.Willing to fast at least 10 hours before attending clinic visit

排除标准

  • 1.Currently pregnant and/or nursing (lactating)
  • 2.Diagnosis of insulin resistance, diabetes (Type I, Type II and/or Gestational Diabetes), cancer including skin cancer, and immunological disease
  • 3.Current or prior chemotherapy/radiotherapy treatment
  • 4.Current use or use of the following medications in the last 84 days prior to clinic visit:
  • Glucophage
  • Glucophage XR
  • N,N-dimethylbiguanide
  • 5.Experienced physical injury 14 days prior to clinic visit that meets any of the following:
  • Required medical assessment and/or treatment
  • Resulted in pain, bruising and/or sensitivity lasting longer than 14 days or is currently being experienced.
  • Resulted in limited movement and mobility
  • 6.Average Systolic BP >=180mmHg or Diastolic BP >= 110mmHg
  • 7.In the opinion of the Principal Investigator, unable to comply and/or experience distress with study procedures.

研究者

相似试验